Sarcoma, Ewing Clinical Trial
Official title:
The Efficacy and Safety of TK216 in Subjects With Relapsed or Refractory Ewing's Sarcoma：a Phase II Clinical Trial in China
This study is a multicenter, single-arm, open-label Phase II clinical trial evaluating TK216 in combination with vincristine in the treatment of relapsed or refractory Ewing sarcoma (ES) including Ewing's sarcoma family tumors (ESFTs).
Ewing sarcoma is characterized by genomic rearrangements resulting in over-expression of ets family transcription factors driving tumor progression. TK216 is designed to inhibit this effect by inhibiting downstream effects of the EWS-FLI1 transcription factor. Based on USA RP2D result, designed as a single arm, multicenter open-label study，this study is the first study of TK216 in Chinese subjects with Ewing sarcoma. The study is designed to establish safety and efficacy data in combination with vincristine to assess the potential of TK216 for further development. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05440786 -
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
|
Phase 2 | |
| Completed |
NCT01661400 -
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
|
Phase 1 | |
| Completed |
NCT03275818 -
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
|
Phase 2 | |
| Recruiting |
NCT06387485 -
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
|
N/A | |
| Not yet recruiting |
NCT04890093 -
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT02415816 -
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
|
N/A | |
| Active, not recruiting |
NCT03778996 -
SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma
|
Phase 2 | |
| Terminated |
NCT02581384 -
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05772312 -
Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
|
||
| Withdrawn |
NCT02557854 -
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
|
Phase 1 | |
| Terminated |
NCT03495921 -
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
|
Phase 3 | |
| Terminated |
NCT02657005 -
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
|
Phase 1/Phase 2 | |
| Completed |
NCT05100368 -
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
|